Related Experiment Video
Updated: May 22, 2025
A High-throughput Method for Measurement of Glomerular Filtration Rate in Conscious Mice
Published on: May 10, 2013
Is Iohexol a Possible Method for Estimating Glomerular Filtration Rate?
Fabrizio Cristiano1, Guillermo Rosa-Diez2, Carlos Guido Musso2
1UOSD Nefrologia e Dialisi Ospedale di Ortona, Asl 2 Lanciano Vasto Chieti.
Insights
The iohexol clearance test offers a precise method for measuring kidney function, crucial for managing chronic kidney disease (CKD) and autosomal dominant polycystic kidney disease (ADPKD). This advanced technique provides reliable glomerular filtration rate (GFR) estimates, improving patient care.
Area of Science:
- Nephrology
- Diagnostic Imaging
- Pharmacokinetics
Background:
- Glomerular filtration rate (GFR) measurement is vital for diagnosing and managing chronic kidney disease (CKD) and autosomal dominant polycystic kidney disease (ADPKD).
- Traditional GFR estimation methods using creatinine or cystatin C can be unreliable due to physiological variations like muscle mass and diet.
- Existing methods like inulin or radioactive tracers have limitations, necessitating more accurate and less invasive alternatives.
Purpose of the Study:
- To describe the procedures for iohexol clearance testing for direct GFR estimation.
- To highlight the accuracy and utility of iohexol clearance in monitoring kidney disease progression, particularly in CKD and ADPKD.
- To evaluate iohexol clearance as a superior alternative to traditional GFR markers.
Main Methods:
- Intravenous administration of iohexol, a non-ionic contrast agent exclusively cleared by glomerular filtration.
- Collection of blood samples at defined intervals post-administration to analyze iohexol elimination kinetics.
- Adjusting sampling intervals based on patient's renal function: more frequent for normal function, wider for advanced CKD and ADPKD.
Main Results:
- Iohexol clearance demonstrated high precision and reproducibility compared to other GFR markers.
- The method effectively monitors the progression of CKD and ADPKD, detecting subtle GFR changes even in early disease stages.
- Iohexol is particularly valuable for evaluating therapeutic interventions in ADPKD by providing reliable GFR estimates.
Conclusions:
- Iohexol clearance is a highly accurate and reproducible method for GFR estimation, offering significant advantages over traditional markers.
- Its application in monitoring CKD and ADPKD progression, especially for evaluating targeted therapies, enhances nephrology practice.
- Despite limitations such as cost and protocol strictness, iohexol clearance is implemented in advanced healthcare settings, confirming its clinical utility.
Abstract:
The measurement of glomerular filtration rate (GFR) is essential in diagnosing and managing chronic kidney disease (CKD) and autosomal dominant polycystic kidney disease (ADPKD), both requiring precise renal function assessment. Traditionally, GFR has been estimated using endogenous markers like creatinine and cystatin C, though these can be inaccurate due to factors unrelated to kidney function, such as muscle mass and diet. The iohexol clearance method provides a more accurate and less invasive alternative to traditional markers like inulin or radioactive markers. Iohexol, a non-ionic, water-soluble contrast agent, is exclusively eliminated by glomerular filtration, making it highly suitable for direct GFR estimation. This paper describes procedures for iohexol clearance, involving defined-interval blood samples after intravenous administration. In patients with normal renal function, sampling intervals are more frequent, while in advanced CKD patients, including those with ADPKD, slower iohexol elimination requires wider intervals to ensure accurate clearance analysis. Iohexol has demonstrated high precision and reproducibility, even compared to other markers. Research supports using iohexol to monitor CKD and ADPKD progression effectively. Particularly in ADPKD, iohexol detects subtle but clinically significant GFR changes, even in early disease stages, making it valuable for evaluating targeted therapies. However, iohexol use is limited to specialized centers due to high costs and strict protocols. Its implementation in advanced European healthcare facilities underscores its efficacy, providing reliable GFR estimates that enhance nephrology practice, despite some limitations.
Related Concept Videos
01:02Renal Drug Excretion: Glomerular Filtration
Drugs gain access to the kidney via the renal artery, which progressively branches off into afferent arterioles....
01:23Renal Clearance
Renal clearance refers to the volume of plasma cleared of a specific substance, such as creatinine, per unit of time. To measure clearance, urine samples are collected over a 24-hour period during each bladder voiding, followed by a single blood sample at the...
01:08Renal Drug Clearance: Comparison Between Renal Excretion Methods
Renal clearance is often associated with the renal glomerular filtration rate (GFR), which represents the rate at which plasma is filtered through the glomeruli in the kidney. When drug reabsorption is minimal and there is no active secretion, renal clearance is closely related to the...
01:17Factors Affecting Renal Clearance: Renal Impairment
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
01:11One-Compartment Open Model: Urinary Excretion Data and Determination of k
01:28Glomerular Filtration Rate and its Regulation
GFR regulation involves two primary intrinsic controls: the myogenic and tubuloglomerular feedback mechanisms.
The myogenic...